Bio-Works signs distribution agreement with Gene Co. in China including Hong Kong S.A.R. and Macau S.A.R.
Bio-Works Technologies (Nasdaq First North) has signed a distribution agreement with the Hong Kong headquartered Gene Company Ltd to import, store, distribute, market, promote and sell all of its products in China including Hong Kong and Macau Special Administrative Regions.Bio-Works is continuing the strategy to expand its presence in the Asian region addressing the development of biosimilars and biopharmaceuticals in the Asian countries. China has rapidly progressed from just producing generics and developing biosimilar drugs to R&D focused development of innovative biologics including